X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (120) 120
male (94) 94
middle aged (93) 93
female (92) 92
adult (82) 82
aged (78) 78
index medicus (56) 56
hematology (52) 52
oncology (44) 44
aged, 80 and over (38) 38
antineoplastic combined chemotherapy protocols - therapeutic use (35) 35
cancer (35) 35
chemotherapy (35) 35
prognosis (30) 30
adolescent (29) 29
non-hodgkins-lymphoma (28) 28
life sciences (26) 26
treatment outcome (26) 26
rituximab (24) 24
lymphomas (23) 23
young adult (21) 21
lymphoma, large b-cell, diffuse - drug therapy (20) 20
disease-free survival (19) 19
retrospective studies (19) 19
survival analysis (19) 19
doxorubicin - administration & dosage (18) 18
expression (18) 18
immunohistochemistry (18) 18
lymphoma (18) 18
pathology (18) 18
survival (18) 18
antineoplastic combined chemotherapy protocols - administration & dosage (17) 17
combined modality therapy (16) 16
cyclophosphamide - administration & dosage (16) 16
disease (16) 16
neoplasm staging (16) 16
survival rate (16) 16
prednisone - administration & dosage (15) 15
prospective studies (15) 15
doxorubicin - therapeutic use (14) 14
lymphoma, large b-cell, diffuse - mortality (14) 14
vincristine - administration & dosage (14) 14
antineoplastic combined chemotherapy protocols - adverse effects (13) 13
b-cell lymphoma (13) 13
biopsy (13) 13
elderly-patients (13) 13
hemic and lymphatic diseases (13) 13
[ sdv.can ] life sciences [q-bio]/cancer (12) 12
abridged index medicus (12) 12
antibodies, monoclonal, murine-derived (12) 12
follow-up studies (12) 12
recurrence (12) 12
therapy (12) 12
[sdv.can]life sciences [q-bio]/cancer (11) 11
care and treatment (11) 11
classification (11) 11
hodgkin lymphoma (11) 11
research (11) 11
cyclophosphamide - therapeutic use (10) 10
doxorubicin (10) 10
hodgkin disease - drug therapy (10) 10
immunophenotyping (10) 10
prednisone - therapeutic use (10) 10
proportional hazards models (10) 10
risk factors (10) 10
cyclophosphamide (9) 9
immune system diseases (9) 9
lymphoma, t-cell - pathology (9) 9
multivariate analysis (9) 9
r-chop (9) 9
transplantation (9) 9
transplantation, autologous (9) 9
vincristine - therapeutic use (9) 9
antibodies, monoclonal - administration & dosage (8) 8
antibodies, monoclonal, murine-derived - therapeutic use (8) 8
child (8) 8
epstein-barr-virus (8) 8
gene expression profiling (8) 8
hodgkin disease - pathology (8) 8
immunology (8) 8
medical research (8) 8
predictive value of tests (8) 8
prednisone (8) 8
radiotherapy (8) 8
analysis (7) 7
antineoplastic agents - therapeutic use (7) 7
biochemistry, molecular biology (7) 7
biomarkers, tumor - metabolism (7) 7
bleomycin - therapeutic use (7) 7
cytarabine - administration & dosage (7) 7
drug therapy (7) 7
follicular lymphoma (7) 7
gene expression regulation, neoplastic (7) 7
hodgkin disease - mortality (7) 7
hodgkin's disease (7) 7
kaplan-meier estimate (7) 7
lymph nodes - pathology (7) 7
lymphoma, b-cell - pathology (7) 7
lymphoma, large b-cell, diffuse - pathology (7) 7
phase-ii (7) 7
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Clinical Oncology, ISSN 0732-183X, 12/2012, Volume 30, Issue 36, pp. 4462 - 4469
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 09/2010, Volume 28, Issue 27, pp. 4184 - 4190
Purpose Salvage chemotherapy followed by high-dose therapy and autologous stem-cell transplantation (ASCT) is the standard treatment for relapsed diffuse large... 
SURVIVAL | PARMA TRIAL | THERAPY | BONE-MARROW TRANSPLANTATION | ONCOLOGY | NON-HODGKINS-LYMPHOMA | CHOP | AGGRESSIVE LYMPHOMA | RANDOMIZED CONTROLLED-TRIAL | CHEMOTHERAPY PLUS RITUXIMAB | ELDERLY-PATIENTS | Recurrence | Humans | Middle Aged | Salvage Therapy | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Transplantation, Autologous | New York City | Stem Cell Transplantation | Young Adult | Time Factors | Lymphoma, Large B-Cell, Diffuse - immunology | Adult | Female | Antigens, CD20 - analysis | Chemotherapy, Adjuvant | Antibodies, Monoclonal, Murine-Derived | Dexamethasone - administration & dosage | Lymphoma, Large B-Cell, Diffuse - drug therapy | Lymphoma, Large B-Cell, Diffuse - surgery | Lymphoma, Large B-Cell, Diffuse - pathology | Risk Assessment | Europe | Risk Factors | Kaplan-Meier Estimate | Proportional Hazards Models | Carboplatin - administration & dosage | Rituximab | Etoposide - administration & dosage | Treatment Outcome | Cytarabine - administration & dosage | Lymphoma, Large B-Cell, Diffuse - mortality | Disease-Free Survival | Ifosfamide - administration & dosage | Antibodies, Monoclonal - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Aged | Israel | Australia | Neoplasm Staging | Bone2 | Original Reports | Hema13 | Clinical Medicine | Medical and Health Sciences | Medicin och hälsovetenskap | MEDICIN | Surgery | Onkologi | Oncology | Cancer and Oncology | Klinisk medicin | MEDICINE | Kirurgi | Cancer och onkologi
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 06/2016, Volume 22, Issue 12, pp. 2919 - 2928
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 01/2002, Volume 346, Issue 4, pp. 235 - 242
Journal Article
Blood, ISSN 0006-4971, 10/2015, Volume 126, Issue 14, pp. 1695 - 1698
The risk of central nervous system (CNS) dissemination in mantle cell lymphoma (MCL) is low and occurs late in the course of the disease. However, prognosis in... 
PCI-32765 | NON-HODGKIN-LYMPHOMA | MALIGNANCIES | TARGETING BTK | HEMATOLOGY | TYROSINE KINASE | Recurrence | Pyrazoles - therapeutic use | Pyrimidines - therapeutic use | Humans | Middle Aged | Lymphoma, Mantle-Cell - drug therapy | Female | Male | Aged | Antineoplastic Agents - therapeutic use | Central Nervous System Neoplasms - drug therapy | Lymphoid Neoplasia | Brief Report
Journal Article
European Journal of Cancer, ISSN 0959-8049, 09/2017, Volume 83, pp. 146 - 153
Long-term outcomes of adults with first-relapsed/refractory (R/R) systemic anaplastic large-cell lymphoma (ALCL) are not definitively established and should be... 
Relapse | Anaplastic large-cell lymphoma | Survival | ALK protein | TRIAL | THERAPY | FINAL REPORT | ONCOLOGY | CRIZOTINIB | NON-HODGKIN-LYMPHOMA | PHASE-II | ALCL | Aluminum compounds | Lymphomas | Adults | Medicine, Experimental | Medical research | Life Sciences | Hematology | Human health and pathology
Journal Article
Blood, ISSN 0006-4971, 02/2010, Volume 115, Issue 6, pp. 1226 - 1237
Biopsies and cell lines of natural killer/T-cell lymphoma, nasal type (NKTCL) were subject to combined gene expression profiling and array-based comparative... 
GRANZYME-H | SURVIVAL | GROWTH | MUTATIONS | LEUKEMIA | COMPARATIVE GENOMIC HYBRIDIZATION | HEMATOLOGY | NF-KAPPA-B | ASSOCIATION | EPSTEIN-BARR-VIRUS | PERIPHERAL T-CELL | Nasopharyngeal Neoplasms - genetics | Nasopharyngeal Neoplasms - metabolism | Cell Proliferation | Oligonucleotide Array Sequence Analysis | Humans | Middle Aged | Nasopharyngeal Neoplasms - virology | Male | Gene Expression Profiling | Killer Cells, Natural - pathology | Nasal Mucosa - pathology | Lymphoma, Extranodal NK-T-Cell - virology | Oncogenes - physiology | RNA, Messenger - metabolism | Immunoenzyme Techniques | Lymphoma, Extranodal NK-T-Cell - genetics | Biomarkers, Tumor - metabolism | Epstein-Barr Virus Infections - genetics | Adult | Female | Nasal Mucosa - metabolism | Epstein-Barr Virus Infections - virology | Signal Transduction | Killer Cells, Natural - virology | Herpesvirus 4, Human - physiology | RNA, Messenger - genetics | Cells, Cultured | Ubiquitin-Protein Ligases - metabolism | Receptors, Platelet-Derived Growth Factor - genetics | Reverse Transcriptase Polymerase Chain Reaction | Blotting, Western | Comparative Genomic Hybridization | Receptors, Platelet-Derived Growth Factor - metabolism | Aged | Biomarkers, Tumor - genetics | Ubiquitin-Protein Ligases - genetics | Epstein-Barr Virus Infections - metabolism | Lymphoma, Extranodal NK-T-Cell - metabolism | Lymphoid Neoplasia
Journal Article
Blood, ISSN 0006-4971, 07/2015, Volume 126, Issue 5, pp. 604 - 611
We revisited the prognostic value of frequently detected somatic gene copy number alterations (CNAs) in mantle cell lymphoma (MCL) patients treated first line... 
PATHOGENESIS | IMMUNOCHEMOTHERAPY | PROBE AMPLIFICATION | RANDOMIZED-TRIALS | MCL | HYBRIDIZATION | ABERRATIONS | HEMATOLOGY | EXPRESSION | HISTOPATHOLOGY | GENETIC ALTERATIONS | Life Sciences
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 11/2011, Volume 29, Issue 31, pp. 4079 - 4087
Purpose To evaluate the prognostic value of the cell of origin (COO) in patients with relapsed/refractory diffuse large B-cell lymphoma (DLBLC), prospectively... 
MOLECULAR SUBTYPES | SURVIVAL | ONCOLOGY | RISK STRATIFICATION | R-CHOP | RITUXIMAB | NON-HODGKINS-LYMPHOMAS | CLASSIFICATION | TISSUE MICROARRAY | ELDERLY-PATIENTS | EXPRESSION | Immunohistochemistry | Multivariate Analysis | Predictive Value of Tests | Recurrence | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Prognosis | Prospective Studies | Humans | Middle Aged | Antibodies, Monoclonal, Murine-Derived - administration & dosage | Gene Expression Regulation, Neoplastic | Male | Gene Expression Profiling | Antigens, CD20 - blood | Cisplatin - administration & dosage | Multicenter Studies as Topic | Microarray Analysis | Lymphoma, Large B-Cell, Diffuse - chemistry | Lymphoma, Large B-Cell, Diffuse - immunology | Adult | Female | Neoplasm Proteins - genetics | Dexamethasone - administration & dosage | Lymphoma, Large B-Cell, Diffuse - drug therapy | Lymphoma, Large B-Cell, Diffuse - pathology | Biomarkers, Tumor - analysis | Risk Factors | Proportional Hazards Models | Carboplatin - administration & dosage | Rituximab | Etoposide - administration & dosage | In Situ Hybridization, Fluorescence | Germinal Center - pathology | Cytarabine - administration & dosage | Randomized Controlled Trials as Topic | Disease-Free Survival | Ifosfamide - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Neoplasm, Residual - drug therapy | Neoplasm Proteins - analysis | Aged | Biomarkers, Tumor - genetics | Salvage Therapy - methods | Clinical Medicine | Medical and Health Sciences | Cancer and Oncology | Klinisk medicin | Medicin och hälsovetenskap | Cancer och onkologi
Journal Article
Journal Article
Journal Article